Medical Breakthrough In New Weight-loss Pill
Eli Lilly says a new pill for obesity, similar to existing GLP-1 medications that can only be injected, is showing promise in a clinical trial.
Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company’s new orforglipron pill can offer up to an average of 27.3 pounds of weight loss, according to results from the first of two of its Phase 3 trials that included more than 3,100 overweight or obese adults.
READ more from GMA: https://tinyurl.com/5dm9uz86
SUBSCRIBE to GMA on YouTube: https://bit.ly/2Zq0dU5
SIGN UP to get the daily GMA Wake-Up Newsletter:
https://tinyurl.com/yc34mz6t
VISIT GMA: https://www.goodmorningamerica.com
FOLLOW:
TikTok: https://tiktok.com/@gma
Instagram: https://instagram.com/GoodMorningAmerica
Facebook: https://facebook.com/GoodMorningAmerica
Threads: https://www.threads.net/@goodmorningamerica
X: https://twitter.com/gma
As seen on YouTube.
Related in [Weight loss]:
- Weight Loss Jab Approved By NHS
- Types Of Weight Loss Surgery | OSF Saint Francis Medical Center
- Baking Soda Tonic For Weight Loss?
- STANDING WEIGHT LOSS WORKOUT – NO JUMPING, NO REPEATS
- Weight Loss Weight Gain
Other posts:
- A MINECRAFT MOVIE – All Trailers From The Movie (2025)
- EXPENSIVE CARS & SPICY FOOD
- Top 20 Movie Trailers That Broke The Internet
- SKIN Official Trailer (2019) Jamie Bell, Drama Movie HD
- Can I Turn Will Tennyson Into A Real Climber?
